美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BlossomHill Therapeutics

21.74

+0.88004.22%

盤後：22.150.4100+1.89%16:48 EDT

成交量：25.43萬

成交額：529.89萬

市值：6.66億

市盈率：-8.90

高：22.08

開：20.90

低：20.45

收：20.86

52周最高：23.37

52周最低：15.25

股本：3,064.37萬

流通股本：937.50萬

量比：1.51

換手率：2.71%

股息：- -

股息率：- -

每股收益(TTM):-2.4440

每股收益(LYR):-24.8342

淨資產收益率：--

總資產收益率：--

市淨率：-4.38

市盈率(LYR):-0.88

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

H.C. Wainwright 首次覆蓋 BlossomHill Therapeutics，給予「買入」評級及35美元目標價

美國研究綜述-Autodesk、Hubspot、Oracle

Blossomhill Therapeutics宣佈其宏環Omni-Egfr™抑制劑Bh-30643獲FDA快速通道資格，用於治療晚期EGFR C797S突變非小細胞肺癌

美股異動 | BlossomHill Therapeutics(BLSM.US)登陸美股市場開盤後股價小幅走低

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BLSM"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BLSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","market":"US","secType":"STK","nameCN":"BlossomHill Therapeutics","latestPrice":21.74,"timestamp":1789416000000,"preClose":20.86,"halted":0,"volume":254306,"hourTrading":{"tag":"盘后","latestPrice":22.15,"preClose":21.74,"latestTime":"16:48 EDT","volume":281,"amount":6113.890096,"timestamp":1789418932762,"change":0.41,"changeRate":0.018859,"amplitude":0.019319},"delay":0,"changeRate":0.04218600191754549,"floatShares":9375000,"shares":30643700,"eps":-2.444,"marketStatus":"盤後交易","change":0.88,"latestTime":"09-14 18:10:10 EDT","open":20.9,"high":22.08,"low":20.445,"amount":5298936.739018001,"amplitude":0.07838,"askPrice":22.16,"askSize":91,"bidPrice":21.08,"bidSize":8,"shortable":3,"etf":0,"ttmEps":-2.444,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":4,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":20.86,"preHourTrading":{"tag":"盘前","latestPrice":21.04,"preClose":20.86,"latestTime":"09:29 EDT","volume":672,"amount":14396.152512,"timestamp":1789392580008,"change":0.18,"changeRate":0.008629,"amplitude":0.095877},"postHourTrading":{"tag":"盘后","latestPrice":22.15,"preClose":21.74,"latestTime":"16:48 EDT","volume":281,"amount":6113.890096,"timestamp":1789418932762,"change":0.41,"changeRate":0.018859,"amplitude":0.019319},"volumeRatio":1.510161},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","floatShares":9375000,"roa":"--","roe":"--","lyrEps":-24.834182,"volumeRatio":1.510161,"shares":30643700,"dividePrice":0,"high":22.08,"amplitude":0.07838,"preClose":20.86,"low":20.445,"week52Low":15.25,"pbRate":"-4.38","week52High":23.37,"institutionHeld":0,"latestPrice":21.74,"committee":-0.838384,"eps":-2.444,"divideRate":0,"volume":254306,"delay":0,"ttmEps":-2.444,"open":20.9,"prevYearClose":16,"prevWeekClose":20.86,"prevMonthClose":18.3,"prevQuarterClose":16,"fiveDayClose":22.01,"twentyDayClose":16.18,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLSM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1789099200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLSM","date":"2026-09-11","current":-8.895254,"percent":0.12,"low":-9.884773,"twenty":-8.535478,"median":-7.091344,"eighty":-6.910289,"high":-2.788792,"avg":-7.593545,"sd":1.350613,"marketCap":659145126},"quantilePoints":[{"date":"2026-08-07","current":-6.897356,"twenty":-6.075643,"median":-4.843074,"eighty":-3.610505,"marketCap":490298560},{"date":"2026-08-14","current":-7.048236,"twenty":-7.038752,"median":-6.897356,"eighty":-6.893907,"marketCap":501023841},{"date":"2026-08-21","current":-6.811139,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"marketCap":484169828},{"date":"2026-08-28","current":-8.535478,"twenty":-7.10945,"median":-6.974951,"eighty":-6.897356,"marketCap":606744468},{"date":"2026-09-04","current":-8.630317,"twenty":-8.140605,"median":-7.054702,"eighty":-6.899943,"marketCap":613486073},{"date":"2026-09-11","current":-9.272633,"twenty":-8.535478,"median":-7.091344,"eighty":-6.910289,"marketCap":659145126}],"updateTime":1789423810793},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLSM\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1146237583","title":"H.C. Wainwright 首次覆蓋 BlossomHill Therapeutics，給予「買入」評級及35美元目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=1146237583","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146237583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:10","pubTimestamp":1788257420,"startTime":"0","endTime":"0","summary":"H.C. Wainwright 正式启动对 BlossomHill Therapeutics 的覆盖研究，并出具“买入”评级。此次覆盖标志着这家投资银行对 BlossomHill Therapeutics 的正式关注，评级结果也凸显出对公司战略方向及产品管线价值的认可。BlossomHill Therapeutics 专注于开发创新疗法，其研发进展及近期里程碑成果，显然已吸引卖方分析师的注意。H.C. Wainwright 的此番表态，或为市场注入新的信心，推动股价向目标价区间靠拢。整体而言，这一初次覆盖为 BlossomHill Therapeutics 的投资者提供了一个新的参考基准，也进一步巩固了其在生物科技领域中的关注度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664367078","title":"美國研究綜述-Autodesk、Hubspot、Oracle","url":"https://stock-news.laohu8.com/highlight/detail?id=2664367078","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664367078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:07","pubTimestamp":1788246438,"startTime":"0","endTime":"0","summary":"美国研究综述-Autodesk、Hubspot、Oracle路透9月1日-周二，华尔街证券分析师修订了包括Autodesk、Hubspot和Oracle在内的几家美国上市公司评级及目标股价。要点* Autodesk IncADSK.O：Berenberg将目标价从335美元下调至333美元* Hubspot IncHUBS.N：TD Cowen将目标价从220美元上调至285美元* Oracle CorpORCL.N：TD Cowen将目标价从300美元下调至240美元* Salesforce IncCRM.N：TD Cowen将目标价从280美元上调至300美元* Workiva IncWK.N：贝尔德将目标价从74美元上调至95美元以下是路透周二报道的针对美国公司的研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4S44T0KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLCK","BK4579","LU1923623000.USD","BK4548","LU0511384066.AUD","LU0661504455.SGD","LU0234570918.USD","LU0528227936.USD","FICO","IGV","ORCL","LU2125910336.SGD","CRPT","LU2361044949.HKD","LU0320765489.SGD","BK4550","LU0433182093.SGD","LU1061106388.HKD","HOII","IE00BQXX3F31.USD","LU0070302665.USD","LU0957791311.USD","LU2247934214.USD","LU0963586101.USD","CRM","SG9999003800.SGD","FDIQ","BK4533","FINX","LU1923621640.USD","LU2764263039.SGD","SG9999011175.SGD","LU1059921491.USD","LU1267930490.SGD","LU0096362180.USD","LU0130102774.USD","GB00B4LPDJ14.GBP","IE00BZ18W340.USD","IE00B894F039.SGD","LU0130518102.USD","LU2210149790.SGD","LU0061474960.USD","LU1046421795.USD","LU2244417387.USD","LU1720051108.HKD","LU2384288077.EUR","LU0566484027.USD","LU2720916845.USD","LU2272731600.USD","BK4561","IE00BMQBXF63.USD","HOYY","LU0210536198.USD","LU0211327993.USD","BWA","LU0048573561.USD","LU0316494557.USD","SG9999013999.USD","IE00B2B36J28.USD","IE00BMPRXN33.USD","LU2404859741.USD","LU2357305700.SGD","IE00B775SV38.USD","WAT","LU0690374615.EUR","SGXZ57979304.SGD","LU0122379950.USD","IE00BN8TJ469.HKD","LU2360108059.USD","HOOX","LU1621768115.EUR","LU0320765059.SGD","LU1934455277.USD","IE00BQXX3D17.EUR","ORCZ","HODU","LU0648000940.SGD","LU1543694498.USD","LU0234572021.USD","LU1983260115.SGD","LU0742534661.SGD","EKG","LU0124676726.USD","LU1691799644.USD","LU2764262908.HKD","LU0689626769.HKD","GB00B4QBRK32.GBP","LU0965509010.AUD","LU0553294199.USD","IE00BJTD4N35.SGD","LU1506573853.SGD","LU0187121727.USD","IE0002270589.USD","LU0878866978.SGD","BK4530","CRMG","LU1989764748.USD","LU0314106906.USD","LU1064131342.USD","HOOC","LU2764263203.CNY","LU1621767737.EUR","IE00BJJMRZ35.SGD","LU0097036916.USD","LU1280957306.USD","RGEN","LU1670627923.USD","LU1261432733.SGD","LU0082616367.USD","LU2433249047.HKD","LU1935043023.USD","LU0861579265.USD","BK4023","LU2250418816.HKD","LU0476273544.USD","LU1878469433.USD","LU0057025933.USD","LU2237957811.SGD","TMO","LU2229751404.USD","BK4007","LU2404859667.USD","LU0266013472.USD","LU1366333091.USD","LU2106854487.HKD","LU0882574055.USD","LU2237957902.USD","LU2458330169.SGD","LU1153585028.USD","IE00BKVL7J92.USD","LU0980610538.SGD","IE00BN0W2V16.EUR","LU0289739343.SGD","LU0323239441.USD","LU1496350171.SGD","LU1935042215.USD","LU0477156953.USD","LU0128525929.USD","LU2458330243.SGD","LU1267930227.SGD","IE00BD6J9T35.USD","WK","LU0314104364.USD","LU0648001328.SGD","LU0994945656.USD","LU1621767810.EUR","LU0107464264.USD","LU0256863811.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU2264538146.SGD","TMED","LU0056508442.USD","LU0310800379.SGD","OKE","LU1621768206.USD","LU0106261612.USD","LU0081259029.USD","HRTS","IE00BJTD4V19.USD","IE00BFTCPJ56.SGD","SG9999001424.SGD","IE00BZ1G4Q59.USD","HOOZ","LU0312595415.SGD","BK4543","IE00B7SZLL34.SGD","LU0820561909.HKD","BK4534","BK4566","HUBS","LU0157215616.USD","LU1267930813.SGD","LU2361045086.USD","HOOY","LU1551013342.USD","LU0965509101.SGD","LU2746668974.SGD","LU1721429741.USD","LU0011850046.USD","LU2413666699.HKD","LU0738911758.USD","LU2125909247.SGD","BK4121","IQV","LU1935042488.USD","IE00BLDYK493.USD","BK4124","LU2413666426.HKD","LU0323591593.USD","LU0238689110.USD","PUI","RVTY","ORCS","LU2286300806.USD","BK4504","SG9999001176.SGD","LU1988902786.USD","LU0345770308.USD","BESF","LU1496350502.SGD","IE00BYQQ9H92.USD","LU1559883803.SGD","LU0342679015.USD","FMED","HOOI","AKAM","LU1267930573.SGD","A","LU0109391861.USD","LU0820562030.AUD","LU1551013425.SGD","LU1854103824.USD","BPAY","LU2087625088.SGD","IE00BN0W2W23.USD","LU0345770993.USD","LU0689472784.USD","LU2054465674.USD","LU0256331488.USD","LU2543165471.USD","OGIG","LU0957808578.USD","LU0211328371.USD","LU0310800965.SGD","LU1429558221.USD","LU1037948897.HKD","HEAL","LU2326559502.SGD","LU0251142724.SGD","LU0545039389.USD","LU1815336091.USD","TXG","IE00B19Z8W00.USD","LU2108987350.USD","LU0310799852.SGD","LU2236285917.USD","LU1721429402.USD","LU2272731782.SGD","LU0889565833.HKD","LU1992135472.HKD","BK4144","ARKG","LU1791710400.SGD","LU1712237335.SGD","IE00B19Z8X17.USD","LU0029864427.USD","LU1093756325.SGD","LU1854104046.USD","LU0965509283.SGD","BK4567","IE00B4R5TH58.HKD","IE0034235188.USD","LU1935042991.SGD","IE00B19Z9Z06.USD","IE00BBT3K403.USD","LU0444973449.USD","LU1721428933.USD","LU0012050646.USD","LU0353189680.USD","LU2238339852.HKD","LU1791710582.SGD","IE00B3S45H60.SGD","IE00BZ18W456.USD","LU0353189763.USD","IE00B5949003.HKD","LU1003077747.HKD","LU1316542783.SGD","BK4554","LU1023059063.AUD","LU1548497426.USD","LU1989771016.USD","LU0354030438.USD","LU1069347547.HKD","IE00B29SXL02.USD","LU1267930730.SGD","LU2211814178.USD","LU0690374961.EUR","LU1804176565.USD","LU1823568750.SGD","BK4607","LU0127658192.USD","LU2125909916.SGD","LU0054578231.USD","LU0128525689.USD","LU0289960550.SGD","LU0640476718.USD","LU0198837287.USD","LU0672654240.SGD","BLSM","IE00BFXG0V08.USD","IE00B29SXK94.USD","LU2089279066.USD","BK4532","IE00BKPKM429.USD","LU2361044865.SGD","LU0477156797.USD","LU0426417589.USD","LU0792757196.USD","LU1814569148.SGD","LU2125909759.SGD","LU2298321311.HKD","LU0267386448.USD","IE00BZ9MQY76.HKD","LU1121112475.USD","TDIV","LU2860962120.EUR","LU1366192091.USD","LU0109392836.USD","IE00B1BXHZ80.USD","MTD","LU0354030511.USD","LU0175139822.USD","MLPI","LU2092937221.SGD","LU0985489474.SGD","LU1623119135.USD","DHR","LU2210150020.SGD","IE0009355771.USD","LU0823416689.USD","LU1057294990.SGD","LU0943347566.SGD","LU0069063385.USD","LU0289961442.SGD","LU1974910355.USD","LU0114720955.EUR","LU1951198990.SGD","LU0251131958.USD","LU1291159041.SGD","LU0006306889.USD","IE00B64QTZ34.USD","LU2211817866.USD","LU0348723411.USD","LU2041044095.USD","BK4116","LU1935043536.SGD","MIDD","LU1489326972.SGD","LU0106261372.USD","BK4608","LU0642271901.SGD","BK4516","LU2298064838.USD","GB00BDT5M118.USD","LU2746668461.USD","IE0004445239.USD","LU2756315318.SGD","LU2896262040.SGD","ORCX","LU1633808545.USD","GTES","LU1989772840.SGD","LU0949170772.SGD","IE00BN0W2T93.GBP","IAI","LU1035773651.USD","AKAL","LU0820561818.USD","IE00BJT1NW94.SGD","LU1043141396.HKD","LU1852331112.SGD","SG9999001176.USD","ROBN","ADSK","GASZ","LU1917777945.USD","LU1201861165.SGD","LU1861559042.SGD","LU0205193047.USD","LU1043141123.HKD","BK4535","LU2089984988.USD","LU0757428866.USD","LU0889566641.SGD","LU0444971666.USD","LU0068578508.USD","LU2461242641.AUD","LU0426412945.USD","LU0208291251.USD","LU2756315664.SGD","LU1803068623.USD","LU0205194284.USD","LU0708995401.HKD","IE00BMPRXQ63.HKD","LU0130517989.USD","IE00B5TLWC47.USD","LU1861558580.USD","LU0345774391.USD","BK4538","LU2063271972.USD","LU1992135399.USD","LU0323240290.USD","BK4613","LU1037948541.HKD","LU0708994859.HKD","ORCU","BK4097","LU1989772923.USD","LU1934455863.HKD","LU2360106780.USD","BK4527","BK4505","SG9999004303.SGD","LU0432979614.USD","LU2468319806.SGD","LU2023250504.SGD","LU0390134368.USD","BK4127","LU1670628061.USD","SORCLmain","LU2125909593.SGD","HOOG","LU1642822529.SGD","IE00B19Z9P08.USD","IE00BLSP4452.SGD","IE00BQXX3C00.GBP","LU0728928796.USD","LU1435385759.SGD","LU2112291526.USD","IE00BMPRXR70.SGD","BK4598","BK4547","LU1939255532.USD","BK4581","LU1815333072.USD","LU2211815571.USD","BK4539","IE00B19Z9505.USD","LU0347712357.USD","LU1235294995.USD","LU1989764664.SGD","BK4588","LU1720051017.SGD","IE0002141913.USD","GNMX","LU1923622614.USD","MLPX","BK4585","LU1093756168.USD","LU1951200564.SGD","LU1803068979.SGD","IE0009356076.USD","SGXZ23171101.USD","LU1165135440.EUR","LU2095319765.USD","IE000M9KFDE8.USD","LU0965508806.USD","ORAC","LU0052756011.USD","LU0719512351.SGD","LU0557290698.USD","HOOW","LU1201861249.SGD","LU1923622291.USD","LU1934455194.USD","LU2265009873.SGD","HOOD","LU0472753341.HKD","LU1815336760.USD","LU2125910179.SGD","BK4528","IE00B19Z3581.USD","LU0130103400.USD","BK4161","LU2355687059.USD","IE00BLSP4239.USD","LU1983299246.USD","LU0345774631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162137187","title":"Blossomhill Therapeutics宣佈其宏環Omni-Egfr™抑制劑Bh-30643獲FDA快速通道資格，用於治療晚期EGFR C797S突變非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1162137187","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162137187?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 19:01","pubTimestamp":1787050871,"startTime":"0","endTime":"0","summary":"Blossomhill Therapeutics今日宣布，美国食品药品监督管理局已授予其候选药物Bh-30643快速通道资格。该药物是一种宏环Omni-Egfr抑制剂，专为治疗携带EGFR C797S突变的晚期非小细胞肺癌患者而设计。这一资格认定意味着Bh-30643有望加速开发和审评进程，以应对当前未被满足的医疗需求。EGFR C797S突变常被视为对现有靶向治疗产生耐药性的关键机制之一，临床挑战严峻。Blossomhill Therapeutics表示，获得快速通道资格是其推进创新疗法过程中的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640472","title":"美股異動 | BlossomHill Therapeutics(BLSM.US)登陸美股市場 開盤後股價小幅走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640472?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 00:00","pubTimestamp":1786118400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，BlossomHill Therapeutics登陆美股市场，截至发稿，该股跌超1%，报15.8美元。BlossomHill Therapeutics总部位于加州圣地亚哥，成立于2020年。该公司专注于通过识别现有治疗方法中的结构性弱点，并设计新的化合物来克服这些弱点，从而开发小分子癌症药物。公司计划于2026年第四季度与美国食品药品监督管理局举行一期临床结束会议，讨论推荐的二期临床给药方案，以及针对部分患者潜在的加速批准路径。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4539","BK4007","BLSM","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BLSM\",params:#limit:6,delay:false,,,undefined,":[]}}